Intelligent Investor

Acumentis Group Limited (ASX: ACU) - Announcements

- Current share price for ACU : $0.081

ASX company news and announcements for Acumentis Group Limited (ACU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acumentis Group Limited (ACU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acumentis Group Limited (ACU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acumentis Group Limited (ACU)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$18 Phase II Pentrix trial to commence 13 Apr 2004 11:28AM $0.325 $0.081 $0.082 fallen by 75.10%
$18 Australian Cancer Tech.Announces Successful Capital Raising 16 Mar 2004 5:41PM $0.294 $0.081 $0.082 fallen by 72.41%
$18 Half Yearly Report & Accounts 27 Feb 2004 1:52PM $0.334 $0.081 $0.082 fallen by 75.77%
$18 Response to ASX Appendix 4C Query 11 Feb 2004 7:05PM $0.298 $0.081 $0.082 fallen by 72.84%
$18 Phase II Anti-Cancer Vaccine Trial Approved 19 Dec 2003 11:32AM $0.190 $0.081 $0.082 fallen by 57.30%
$18 Commitments Test Entity - First Quarter Report 27 Oct 2003 3:03PM $0.172 $0.081 $0.082 fallen by 52.82%
$18 Preliminary Final Report 12 Sep 2003 2:04PM $0.203 $0.081 $0.082 fallen by 60.16%
$18 Important Cancer Drug Discovery from AustCancer JV 1 Sep 2003 11:40AM $0.226 $0.081 $0.082 fallen by 64.14%
$18 New CEO Appointment & Capital Raising 14 Aug 2003 12:51PM $0.154 $0.081 $0.082 fallen by 47.27%
$18 Acquisition of US Cancer Care Business 14 Aug 2003 12:50PM $0.154 $0.081 $0.082 fallen by 47.27%
$18 Phase II Trials for Anti-Cancer Vaccine 2 Jul 2003 11:12AM $0.118 $0.081 $0.082 fallen by 31.06%

501 - 511 of 511 results

Page 21 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.